mercredi 21 octobre 2015

Zacks: Pharming Group Receives Consensus Rating of “Strong Buy” from Analysts

Pharming Group (NASDAQ:PHGUF) has received a consensus broker rating score of 1.00 (Strong Buy) from the two brokers that cover the company, Zacks Investment Research reports. Two research analysts have rated the stock with a strong buy rating.

Analysts have set a 12 month consensus target price of $3.00 for the company, according to Zacks. Zacks has also assigned Pharming Group an industry rank of 92 out of 265 based on the ratings given to its competitors.